Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tanya Trippett, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Stanford University School of Medicine and Stanford Cancer Institute
Palo Alto, California, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Pennsylvania State Hershey Children'S Hospital
Hershey, Pennsylvania, United States
- University of Texas
San Antonio, Texas, United States
- Huntsman Cancer Institue
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2016
- Primary completion
- 31 Oct 2026
- Completion
- 31 Oct 2026
- Last update posted
- 5 Dec 2025
- Registered enrollment
- 14
- Registry id
- NCT02932280
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.